Recce Ltd has released a press release.
Anti-viral Activity
Filed with ASX ·
On 6ix: 6ix.com/news/anti-viral-activity
6ix hasn’t read this filing yet.
Recce Pharmaceuticals Ltd. on 6ix
Earlier from Recce Pharmaceuticals
- Update on Testing Schedules
- Encouraging Results from Safety Test
- Recce - The Way Forward
- Progress Update
- International Trade Mark Registrations
Later from Recce Pharmaceuticals
- Successful Test Results for Genetic Toxicity
- Dose Ranging in Mice - Repeated Success
- Pre-clinical toxicology and efficacy testing
- Encouraging anti-viral activity for lead compound RECCE 327
- Lead compound reduces illness in mice infected by E.coli
Follow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals